Crossmark

Omentin-1 mitigates non-alcoholic fatty liver disease by preserving autophagy through AMPKα/mTOR signaling pathway

Published Online: 2024-12-28

Authors

Huang, Ziqing

Luo, Linfei

Xiao, Zhihua

Xiong, Ming

Wen, Zhili
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81960440)
License Information

Text and Data Mining valid from 2024-12-28

Version of Record valid from 2024-12-28
More Information

Article History

Received: 24 March 2024

Accepted: 11 December 2024

First Online: 28 December 2024

Declarations

:

: The authors declare no competing interests.

Document is current